The mechanisms of adrenocortical tumorigenesis are still not fully understood. Data from clonal analysis, comparative genomic hybridization, and allelotyping suggest that it involves a multistep process during which several genetic defects are progressively acquired, leading to the malignant transformation. The events involved in the first steps of this process are not well known, and most of the abnormalities described in adrenocortical tumors to date are associated with the malignant phenotype. We report a case that suggests that adrenocortical tumorigenesis may be a multistep process. A 43-yr-old patient underwent surgery for an incidentally discovered adrenal mass. Pathological analysis showed that this tumor consisted of two parts: a central part with features of malignancy surrounded by another part with a strictly benign appearance. These data were confirmed by molecular analysis and comparative genomic hybridization that were consistent with either a malignant or benign presentation. The apparently malignant part of the tumor exhibited molecular abnormalities [17p13 loss of heterozygosity (LOH), 11p15 uniparental disomy and overexpression of the IGF-II gene] as well as chromosomal gains and losses (comparative genomic hybridization) that have been previously described in malignant tumors. No abnormalities were found in the surrounding benign tissues. Although this observation is not definitive proof that adrenocortical tumorigenesis occurs via a multistep process, it suggests that there is a progressive change from the benign to the malignant state in some adrenocortical tumors.

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2002-021117DOI Listing

Publication Analysis

Top Keywords

adrenocortical tumorigenesis
16
comparative genomic
12
genomic hybridization
12
multistep process
12
analysis comparative
8
adrenocortical tumors
8
adrenocortical
6
malignant
6
case report
4
report favor
4

Similar Publications

Background: Adrenocortical cancer (ACC) is rare and aggressive, with YAP1 overexpression associated with poor outcomes in pediatric patients. In this study, we investigated the mechanisms by which YAP1 drives ACC progression and explored it as a potential target therapy.

Methods: YAP1 expression and methylation in ACC were analyzed from pediatric and adult cohorts.

View Article and Find Full Text PDF

Adrenocortical cancer (ACC) is a rare malignant neoplasm originating from the adrenal cortex, presenting limited therapeutic options. An avenue for improving therapeutic efficacy may involve a deeper understanding of the role of adrenocortical stem/progenitor cells in the pathogenesis of this disease. Although existing data suggest stem/progenitor characteristics in certain cell populations within ACC, the challenge remains to identify adrenocortical stem cell markers directly involved in its carcinogenesis.

View Article and Find Full Text PDF

A novel lynch syndrome kindred with hereditary adrenal cortical carcinoma.

Cancer Genet

November 2024

Eastern Virginia Medical School, Norfolk, VA, USA; Virginia Oncology Associates, Norfolk, VA, USA.

Article Synopsis
  • Adrenal cortical carcinoma (ACC) is a rare and aggressive cancer, often with a poor prognosis, underscoring the necessity for early detection and treatment through surgical resection.
  • This case study features a 59-year-old man with a hereditary form of ACC linked to Muir-Torre syndrome, indicating a connection between Lynch syndrome and increased risk of this malignancy, particularly in families with a history of ACC.
  • The findings stress the importance of targeted cancer screening for individuals with Lynch syndrome and the critical need for distinct germline and somatic genetic testing in cancer cases to better inform treatment options.
View Article and Find Full Text PDF

Adrenocortical tumors and hereditary syndromes.

Expert Rev Endocrinol Metab

November 2024

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Introduction: Adrenocortical tumors (ACTs) are frequently encountered in clinical practice. They vary in clinical and biological characteristics from nonfunctional to life threatening hormone excess, from benign to highly aggressive malignant tumors. Most ACTs appear to be benign and nonfunctioning.

View Article and Find Full Text PDF
Article Synopsis
  • Epstein-Barr virus (EBV) infection is linked to various cancers, but the role of EB nuclear antigen 1 binding protein 2 (EBNA1BP2) in tumors is not well understood, prompting an investigation into its potential as a prognostic biomarker across multiple cancer types.
  • Utilizing extensive bioinformatics analyses on data from TCGA and GEO databases, the study assessed EBNA1BP2's expression, prognostic significance, immune infiltration, and methylation levels in pan-cancer.
  • Results indicated that higher EBNA1BP2 expression is seen in tumor tissues, with lower levels correlating to better survival rates in specific cancers; it also plays roles in cell cycle regulation, DNA repair, and immune cell
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!